UPM Institutional Repository

2,4,6,-trihydroxy-3-geranylacetophenone (tHGA) suppresses chronic allergic airway inflammation in ovalbumin-sensitized mice via intraperitoneal route


Citation

Ismail, Norazren and Jambari, Nuzul Noorahya and Tham, Chau Ling and Harith, Hanis Hazeera and Shaari, Khozirah and Israf Ali, Daud Ahmad (2019) 2,4,6,-trihydroxy-3-geranylacetophenone (tHGA) suppresses chronic allergic airway inflammation in ovalbumin-sensitized mice via intraperitoneal route. Malaysian Journal of Medicine and Health Sciences, 15 (SP2). pp. 2-9. ISSN 1675-8544; ESSN: 2636-9346

Abstract

Introduction: Asthma is a condition characterized by eosinophilic airway inflammation and remodelling that involves several pathological changes, including subepithelial fibrosis, mucus hypersecretion, smooth muscle growth, and vascular changes. The present study aimed to determine the effect of tHGA administered intraperitoneally in a chronic asthma mouse model that closely mimics the human asthma. Methods: Ovalbumin-sensitized and challenged BALB/c mice were i.p. administered with tHGA at different doses (20 and 2 mg/kg). Respiratory function was measured, and brochoalveolar lavage, blood and lung samples were then obtained and analyzed. Results: The airways of OVA-induced mice developed increased pulmonary inflammation with increased levels of cytokines, chemokines, and changes in vascular permeability. Intraperitoneal administration of tHGA in OVA-induced mice significantly and dose-dependently inhibited the airway inflammation, production of immunoglobulin E, Th2-type cytokines and chemokines, and inflammatory mediators. Treatment with tHGA also significantly reduced the airway hyperresposiveness in response to increased methacholine doses. Conclusion: This study demonstrates that the efficacy of tHGA in alleviating chronic asthmatic symptoms in mouse model improved significantly when administered intraperitoneally compared to oral route. Furthermore, this study also supports that tHGA has a therapeutic potential in chronic asthma management by acting as a cysteinyl leukotrienes (CysLT) inhibitor.


Download File

[img]
Preview
Text
2019070209570201_MJMHS_SP2_2019.pdf

Download (1MB) | Preview

Additional Metadata

Item Type: Article
Divisions: Faculty of Food Science and Technology
Faculty of Medicine and Health Science
Institute of Bioscience
Institute of Tropical Agriculture and Food Security
Publisher: Faculty of Medicine and Health Sciences, Universiti Putra Malaysia
Notes: Special issues: Advancement in Biomedical Sciences
Keywords: Asthma; Airway hyperresponsiveness; Airway remodelling; Cysteinyl leukotrienes; tHGA
Depositing User: Nabilah Mustapa
Date Deposited: 16 Aug 2019 00:38
Last Modified: 16 Aug 2019 00:38
URI: http://psasir.upm.edu.my/id/eprint/70021
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item